May 20, 2020: Washington and Public Policy: COVID-19 Impact on Cancer Care and Road to Recovery

AVBCC COVID-19 Webcast Series Replays, COVID-19

Featuring:

Deborah Kamin, RN, PhD
Vice President
Policy and Advocacy
American Society of Clinical Oncology
Ted Okon, MBA
Executive Director
Community Oncology Alliance
Washington, DC
John O’Brien, PharmD, MPH
Former Senior Advisor to Secretary of US Department Health and Human Services
Jayson Slotnik, JD, MPH
Managing Partner
Health Policy Strategies, Inc.
Bethesda, MD
Burt Zweigenhaft, PhD, D.Litt
Editor-in-Chief, VBCC;
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care
The federal government is an active participant in shaping healthcare policy and delivering care. The panelists in this session addressed the government’s response to COVID-19 and weighed in on some of the issues that their agencies frequently encountered as medical practices grapple with the new normal.

Related Articles

mRNA COVID-19 Vaccine Appears Safe and Effective in Patients with Cancer Receiving Active Treatment
By Chase Doyle
COVID-19
February 2022, Vol 13, No 1 Online Only
Read Article
Current and Future Effects of the COVID-19 Pandemic on Cancer Care
By Phoebe Starr
COVID-19
June 2021, Vol 12, No 3
Read Article
Later Diagnoses, Worse Outcomes in Patients with Lung Cancer During COVID-19 May Last
By Walter Alexander
COVID-19, Lung Cancer
April 2021, Vol 12, No 2
Read Article

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
© Amplity Health. All Rights Reserved. Privacy Policy.